Asher Rubin, co-leader of the life sciences practice at Hogan Lovells joins Sidley Austin in Washington, D.C. He is joined by Adriana Tibbitts.

Asher and Adriana represent both private and publicly traded businesses, academic medical centers, inventors, and venture capital and private equity funds in a wide variety of transactions.

Asher has comprehensive knowledge of the full spectrum of the life sciences sector: pharmaceuticals, biotechnology, medical devices, medical technology, digital health, and health services.

Throughout his career he has worked with clients on some of the most exciting new technologies in the life sciences industry, such as CAR-T therapies, checkpoint inhibitors, co-stimulatory proteins, companion diagnostics, digital health technologies, ultra-orphan drugs, and gene therapies.